3/31
09:21 am
nmra
Neumora Therapeutics (NMRA) had its "buy" rating reaffirmed by Guggenheim. They now have a $14.00 price target on the stock.
Low
Report
Neumora Therapeutics (NMRA) had its "buy" rating reaffirmed by Guggenheim. They now have a $14.00 price target on the stock.
3/31
09:21 am
nmra
Neumora Therapeutics (NMRA) had its "buy" rating reaffirmed by Guggenheim. They now have a $14.00 price target on the stock.
Low
Report
Neumora Therapeutics (NMRA) had its "buy" rating reaffirmed by Guggenheim. They now have a $14.00 price target on the stock.
3/31
09:13 am
nmra
Rating for NMRA
Low
Report
Rating for NMRA
3/31
09:13 am
nmra
Rating for NMRA
Low
Report
Rating for NMRA
3/31
08:02 am
nmra
Neumora Therapeutics (NMRA) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $8.00 price target on the stock.
Low
Report
Neumora Therapeutics (NMRA) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $8.00 price target on the stock.
3/31
06:32 am
nmra
Rating for NMRA
Low
Report
Rating for NMRA
3/31
06:32 am
nmra
Rating for NMRA
Low
Report
Rating for NMRA
2/17
10:20 am
nmra
Rating for NMRA
Medium
Report
Rating for NMRA
2/17
10:20 am
nmra
Rating for NMRA
Medium
Report
Rating for NMRA
2/17
07:23 am
nmra
Neumora Therapeutics (NASDAQ:NMRA) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.
Medium
Report
Neumora Therapeutics (NASDAQ:NMRA) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.
2/17
07:23 am
nmra
Neumora Therapeutics (NASDAQ:NMRA) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.
Medium
Report
Neumora Therapeutics (NASDAQ:NMRA) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.
2/17
06:00 am
nmra
Neumora upgraded to Outperform from Market Perform at William Blair
Medium
Report
Neumora upgraded to Outperform from Market Perform at William Blair
2/17
06:00 am
nmra
Neumora upgraded to Outperform from Market Perform at William Blair
Medium
Report
Neumora upgraded to Outperform from Market Perform at William Blair